BIO Asia–Taiwan 2025 亞洲生技大會

BIO Asia–Taiwan 2025 亞洲生技大會

PROGRAM

2025 Satellite Symposia

​​

Jul.24

LumiSTAR & Molecular Devices Session

Room 402C, Hall 1

Date / Time :July 24 13:00-17:00

Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 402C)

Jul.24

TAIWAN BIO THERAPEUTICS Session

Room 403, Hall 1

Date / Time : July 24 09:00-17:00

Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 403)

Jul.24

Promega Session-Innovating Biologics: Accelerating Drug Discovery and Development with Functional Bioassays

Room 503, Hall 1

Date / Time : July 24 13:00–17:30

Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 503)

Co-organizer : Promega Corporation

Time Topic Speaker
13:00-13:30

Registration

 
13:30

Opening

LayPing Lee
Director, Sales & Marketing
Promega Corporation, Singapore

13:35-14:20

Illuminating Biologics Drug Discovery with Innovative Assays

Dr. Frank Fan
Head of Biology, R&D
Promega Corporation, U.S.A

14:20-15:20

The Bioluminescent Toolbox for Vaccine Characterization and mRNA Quality Control

Dr. Jamison Grailer
Senior Research Scientist
Promega Corporation, U.S.A

15:20-15:50

Promega Bioassays: Enabling Reliable Methodology for Research and Industrial Advancement

Dr. Mei-Wei Lin
Manager
Industrial Technology Research Institute

15:50-16:00

Break

 
16:00-16:30

Bioassays Development for Product Release and Characterization - From a CDMO Perspective

Dr. Toby Hong
Associate Director of Analytical/Formulation Development & Cell Line/Cell Culture Process Development
Bora Biologics

16:30-17:20

Bioluminescent Platform Technologies for Functional Characterization of Advanced Cancer Therapeutics

Dr. Jamison Grailer
Senior Research Scientist
Promega Corporation, U.S.A

17:20

Closing

Dr. Frank Fan
Head of Biology, R&D
Promega Corporation, U.S.A

Jul.25

BIONET Session

Room 402AB, Hall 1

Date / Time : July 25 13:00-17:00

Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 402AB)

Jul.25

Breaking into the US Healthcare Innovation Market

Room 404, Hall 1

Date / Time : July 25 14:00-17:00

Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 404)

Organizer : Department of Industrial Technology, MOEA

Co-organizer : Metal Industries Research & Development Centre, AG CORP, QUAY, KENTRON

Time Topic Speaker
14:00-14:30

Admission

 
14:30-14:35

Opening Remarks & Group Photo

Representative from Department of Industrial Technology, MOEA

14:35-15:05

US AI Healthcare Market and Innovation

Dov Shamir, PhD
Founding Head of Elementa Labs
Mount Sinai Health System

15:05-15:35

Challenges of U.S. Market Expansion: An International Entrepreneur’s Perspective

Vivian Feng
CEO of AG CORP

15:35-16:05

The Role of Accelerators in the Scaling-Up Stage

John Lynn
Co-Founder of QUAY

16:05-16:35

Navigating U.S. FDA Regulations and Government Grants (e.g., SBIR/STTR)

Kenny Wang
CEO of KENTRON

16:35-17:00

Panel Discussion

Moderator:

Vivian Feng, CEO of Accelerator Guardian Corp.

Panelists:

Dov Shamir, John Lynn, Kenny Wang

Session Synopsis:
This session explores essential strategies for healthcare innovators seeking to enter the competitive US market. We'll examine regulatory pathways through the FDA, reimbursement considerations, partnership opportunities, and investment landscapes unique to the American healthcare ecosystem. Experts will share insights on navigating complex stakeholder relationships, addressing market-specific challenges, and positioning your innovation for successful commercialization. Whether you're developing medical devices, biotech solutions, digital health tools, or other healthcare innovations, you'll gain practical knowledge to develop a robust US market entry strategy.

Jul.25

Purple Win Session

Room 503, Hall 1

Date / Time : July 25 13:00–17:00

Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 503)

Jul.25

Bora Session

Room 506, Hall 1

Date / Time : July 25 09:30–12:00

Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 506)